Gyre Therapeutics(GYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GYRE Gyre Therapeutics

休市中 09-11 16:00:00 EDT

6.73

-0.01

-0.15%

盘后6.73

+0.000.00%

19:30 EDT

最高6.95	最低6.73	成交量6.98万
今开6.86	昨收6.74	日振幅3.26%
总市值7.50亿	流通市值2.42亿	总股本1.12亿
成交额47.48万	换手率0.19%	流通股本3,593万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":6.73,"timestamp":1789156800000,"preClose":6.74,"halted":0,"volume":69803,"hourTrading":{"tag":"盘后","latestPrice":6.73,"preClose":6.73,"latestTime":"19:30 EDT","volume":1335,"amount":8984.55,"timestamp":1789169408547,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014836795252225203,"floatShares":35934500,"shares":111509800,"eps":-0.190324,"marketStatus":"休市中","change":-0.01,"latestTime":"09-11 16:00:00 EDT","open":6.86,"high":6.95,"low":6.73,"amount":474773.829875,"amplitude":0.032641,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.190324,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.74,"postHourTrading":{"tag":"盘后","latestPrice":6.73,"preClose":6.73,"latestTime":"19:30 EDT","volume":1335,"amount":8984.55,"timestamp":1789169408547,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6636086218465911,"impliedVol":2.2667,"impliedVolPercentile":0.9084},"requestUrl":"/m/hq/s/GYRE","defaultTab":"news","newsList":[{"id":"1127191297","title":"Gyre Therapeutics：计划于2026年底前在美国提交新药临床试验申请；若申请生效，将启动二期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1127191297","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127191297?lang=zh_cn&edition=full","pubTime":"2026-05-13 05:09","pubTimestamp":1778620168,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics宣布，公司计划在2026年年底前向美国监管机构提交一份新药临床试验申请。若该申请顺利生效，公司计划随即启动针对相关疗法的二期临床试验阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165003303","title":"Gyre Therapeutics宣布NMPA受理F351（氢化尼酮）治疗慢性乙型肝炎所致肝纤维化的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1165003303","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165003303?lang=zh_cn&edition=full","pubTime":"2026-05-13 04:06","pubTimestamp":1778616386,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics宣布，其用于治疗慢性乙型肝炎所致肝纤维化的新药F351（氢化尼酮）的新药申请，已获得中国国家药品监督管理局的正式受理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518278808","title":"Gyre Therapeutics, Inc.盘中异动 快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518278808?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:44","pubTimestamp":1741614262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时44分，Gyre Therapeutics, Inc.股票出现波动，股价快速跳水5.04%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214423abf30134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214423abf30134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516367029","title":"Gyre Therapeutics, Inc.盘中异动 早盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516367029?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:49","pubTimestamp":1741099741,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时49分，Gyre Therapeutics, Inc.股票出现异动，股价大幅跳水5.03%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224901abe7f54c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224901abe7f54c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516652358","title":"Gyre Therapeutics, Inc.盘中异动 股价大跌5.30%报10.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516652358?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:33","pubTimestamp":1741026798,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时33分，Gyre Therapeutics, Inc.股票出现异动，股价急速下挫5.30%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023318abe6790c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023318abe6790c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167510703","title":"异动解读 | Gyre Therapeutics盘中大涨8.53% 疗效数据或成利好驱动因素","url":"https://stock-news.laohu8.com/highlight/detail?id=1167510703","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167510703?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:47","pubTimestamp":1740494854,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics今日盘中大涨8.53%,引发市场关注。这家生物制药公司主攻治疗肝纤维化相关药物研发,近期可能有利好推动股价上涨。Gyre Therapeutics目前正在研发一种治疗多种慢性肝病肝纤维化的药物 Hydronidone。市场对该药物疗效数据充满期待,有助于推升公司股价。除了 Hydronidone 外,Gyre Therapeutics在中国地区还有多个在研管线药物,包括吡非尼酮、F573、F528 和 F230 等。丰富的产品管线有望为公司带来长期的增长动力。投资者对该公司长期发展前景抱有信心,股价自然受到提振。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Gyre Therapeutics盘中大涨8.53% 疗效数据或成利好驱动因素","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090616","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速上涨5.50%报11.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090616?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493923,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨5.50%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223203a25386e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223203a25386e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514477545","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514477545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514477545?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:11","pubTimestamp":1740413509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时11分，Gyre Therapeutics, Inc.股票出现异动，股价快速下跌5.37%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001149abdb254f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001149abdb254f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513215200","title":"Gyre Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报11.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513215200?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:15","pubTimestamp":1740161710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时15分，Gyre Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报11.93美元/股，成交量3.3733万股，换手率0.04%，振幅6.21%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021511abd7df24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021511abd7df24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512238166","title":"Gyre Therapeutics, Inc.盘中异动 大幅拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512238166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512238166?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:34","pubTimestamp":1739889246,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时34分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223406962797aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223406962797aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509177814","title":"Gyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509177814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509177814?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:58","pubTimestamp":1738954723,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时58分，Gyre Therapeutics, Inc.股票出现异动，股价急速跳水5.25%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025843987dda7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025843987dda7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509237702","title":"Gyre Therapeutics, Inc.盘中异动 下午盘急速上涨5.22%报12.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509237702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509237702?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:36","pubTimestamp":1738780597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时36分，Gyre Therapeutics, Inc.股票出现波动，股价快速拉升5.22%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.23%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023639987ba2b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023639987ba2b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506894933","title":"Gyre Therapeutics, Inc.盘中异动 快速上涨5.05%报11.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506894933?lang=zh_cn&edition=full","pubTime":"2025-01-25 02:32","pubTimestamp":1737743526,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日02时32分，Gyre Therapeutics, Inc.股票出现波动，股价快速上涨5.05%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023206a22e8d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023206a22e8d62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503774571","title":"Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503774571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503774571?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:41","pubTimestamp":1736865717,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时41分，Gyre Therapeutics, Inc.股票出现异动，股价快速上涨5.11%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224158abaaaf5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224158abaaaf5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502864743","title":"Gyre Therapeutics, Inc.盘中异动 急速上涨6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502864743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502864743?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519528,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨6.97%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为901.72%、131.67%、105.87%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为15.25%、10.00%、8.90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102232089861e7b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102232089861e7b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501788548","title":"Gyre Therapeutics, Inc.盘中异动 大幅上涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501788548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501788548?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:44","pubTimestamp":1736261061,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时44分，Gyre Therapeutics, Inc.股票出现波动，股价急速拉升5.34%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224421a218ea7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224421a218ea7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501255121","title":"Gyre Therapeutics, Inc.盘中异动 快速下挫5.00%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501255121?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:01","pubTimestamp":1736175699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时01分，Gyre Therapeutics, Inc.股票出现异动，股价急速下跌5.00%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230139985ced98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230139985ced98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500364252","title":"Gyre Therapeutics, Inc.盘中异动 快速下挫5.06%报12.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500364252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500364252?lang=zh_cn&edition=full","pubTime":"2025-01-01 04:14","pubTimestamp":1735676044,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时14分，Gyre Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101041405a210ca79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101041405a210ca79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494336722","title":"Gyre Therapeutics, Inc.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494336722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494336722?lang=zh_cn&edition=full","pubTime":"2024-12-28 02:14","pubTimestamp":1735323267,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日02时14分，Gyre Therapeutics, Inc.股票出现异动，股价快速下跌5.03%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228021427ab951d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228021427ab951d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494864954","title":"Gyre Therapeutics, Inc.盘中异动 股价大涨5.25%报12.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494864954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494864954?lang=zh_cn&edition=full","pubTime":"2024-12-26 23:53","pubTimestamp":1735228380,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时53分，Gyre Therapeutics, Inc.股票出现异动，股价急速拉升5.25%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226235300a20aa702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226235300a20aa702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gyretx.com","stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":0.0105},{"period":"3month","weight":0.1349},{"period":"6month","weight":-0.1092},{"period":"1year","weight":-0.1712},{"period":"ytd","weight":-0.0467}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gyre Therapeutics, Inc.是一家于1997年3月7日在特拉华州注册成立的公司。该公司及其子公司是一家生物制药公司，专注于开发和治疗器官纤维化及炎症性疾病的小分子疗法。通过成功研发并推出治疗肺纤维化的产品艾思瑞（吡非尼酮），公司在华建立了坚实的商业基础，并成为肺纤维化治疗领域的知名参与者。通过向美国拓展，公司正推进包括用于肝纤维化的F351（羟尼酮）在内的在研产品管线。其战略核心是利用已上市产品支持后期开发，应对纤维化及相关炎症性疾病中未被满足的医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.0674},{"month":2,"riseRate":0.545455,"avgChangeRate":0.018198},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.092501},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.002085},{"month":5,"riseRate":0.363636,"avgChangeRate":0.076464},{"month":6,"riseRate":0.454545,"avgChangeRate":0.019825},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.023409},{"month":8,"riseRate":0.636364,"avgChangeRate":0.040292},{"month":9,"riseRate":0.25,"avgChangeRate":-0.132741},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.037523},{"month":11,"riseRate":0.545455,"avgChangeRate":0.207378},{"month":12,"riseRate":0.454545,"avgChangeRate":0.054047}],"exchange":"NASDAQ","name":"Gyre Therapeutics","nameEN":"Gyre Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gyre Therapeutics(GYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gyre Therapeutics(GYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gyre Therapeutics,GYRE,Gyre Therapeutics股票,Gyre Therapeutics股票老虎,Gyre Therapeutics股票老虎国际,Gyre Therapeutics行情,Gyre Therapeutics股票行情,Gyre Therapeutics股价,Gyre Therapeutics股市,Gyre Therapeutics股票价格,Gyre Therapeutics股票交易,Gyre Therapeutics股票购买,Gyre Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gyre Therapeutics(GYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gyre Therapeutics(GYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}